MARAVAI LIFESCIENCES HLDGS-A (MRVI)

Super-investor holdings · 2026 Q2

Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the 90 days to Oct 3, 2026.

Politician trading · U.S. House

Data unavailable — no House STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).

Screens & lenses

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Red Flags

· Financial Restatement (8-K 4.02) — Last 3 years: a non-reliance / restatement filing (8-K Item 4.02)

· Auditor Change (8-K 4.01) — Last 2 years: an auditor change filing (8-K Item 4.01)

· Late Filings (NT) — Last 2 years: a late-filing notification (NT form)

Key figures

· Financial Restatement (8-K 4.02) — Latest event: Mar 18, 2025 · Events in 3 yrs: 1

· Auditor Change (8-K 4.01) — Latest event: Jul 18, 2025 · Events in 2 yrs: 1

· Late Filings (NT) — Latest event: Mar 4, 2025 · Events in 2 yrs: 1 · Latest form: NT 10-K

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2024 Q4, ranked #34 of 50.

Measured from SEC 13F filings: entry at each quarter’s filing deadline (the first day the list was public), exit one quarter later, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.